once they are FDA approved and people sit up and start paying attention (and buying stock) in the US, analysts will want to do some calcs for valuing the company
so for their market segment/industry, what PE ratio will be applied for Now and future earnings (expected revenues to be booked later)
knowning the PEs applied for others in a similar space, (yes I know, AVH will/are making their own with perhaps only TIS being a close equal), will help understand how undervalued AVH is atm
lastly, and because I'm plain lazy, can any throw up some rough figures on EU revenues for this year, and projected for next? just rough figs will do
can anyone help?
good luck
once they are FDA approved and people sit up and start paying...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.69 |
Change
-0.060(2.18%) |
Mkt cap ! $186.3M | |||
| Open | High | Low | Value | Volume |
| $2.67 | $2.71 | $2.64 | $444.7K | 165.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9999 | $2.69 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.71 | 5205 | 2 |
View Market Depth
| Last trade - 16.10pm 21/08/2024 (20 minute delay) ? |
| AVH (ASX) Chart |